Biotechnology
Biomaterials, assay platforms and diagnostic systems developed with affordability and accessibility as explicit design constraints.
Designing for the setting it will be used in
Our founding objectives commit the Center to develop, test and validate biotechnological products, biomaterials and diagnostic systems with a focus on innovation, affordability and accessibility. In practice, that last pair of words changes the engineering.
A method that requires continuous cold chain, an uninterrupted power supply, an expensive proprietary reagent or a highly specialised operator may be excellent science and still be undeployable across much of the country. We treat those constraints as part of the specification rather than as limitations to be complained about later, because a design that ignores them produces a result nobody can use.
What we develop
Diagnostic systems
Assay platforms
Biomaterials
Sample preparation
Validation
Cost engineering
How a method is taken forward
- 01
Define the need
Start from a clinical or public health question and the real conditions the method must work under.
- 02
Develop
Build the method, tracking cost, equipment requirements and operator skill alongside performance.
- 03
Validate
Establish sensitivity, specificity and reproducibility against reference methods and real samples.
- 04
Transfer
Document the protocol so another laboratory can adopt it, and support them while they do.
Turning a validated method into a usable product
Where a developed method has a route to wider deployment, our innovation programme supports that step through incubation and partnership.
Develop something with us
If you are working on a diagnostic or biomaterial problem where cost and accessibility matter, we would be glad to talk.